AI Article Synopsis
- A 64-year-old man with a history of pancreatitis was admitted to the hospital due to ongoing abdominal pain for 8 months, and imaging revealed an enlarged pancreas with no normal tissue.
- Following a suspicion of pancreatic cancer, the patient underwent laparoscopic surgery and a partial pancreatectomy.
- Immunohistochemistry confirmed the diagnosis as pancreatic squamous cell carcinoma, and subsequent imaging showed multiple masses in the abdominal wall post-surgery.
Article Abstract
A 64-year-old man was admitted to the hospital due to "recurrent abdominal pain for 8 months" and had a history of multiple episodes of pancreatitis. CT scan showed an enlarged pancreas with no normal pancreatic tissue . Contrast enhancement scan in the arterial phase displayed moderate enhancement in the solid portion, while the cystic necrosis area showed no enhancement. It was suspected to be pancreatic cancer, and laparoscopic exploration of the pancreas followed by partial pancreatectomy was performed. Finally, it was confirmed as pancreatic squamous cell carcinoma by immunohistochemistry (P63 (+), CK5/6 (+)). Seven days after the operation, F18-FDG PET/CT showed multiple soft tissue density masses in the upper abdominal wall along the laparoscopic trajectory with increased uptake.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17235/reed.2024.10907/2024 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Interferon-ε loss is elusive 9p21 link to immune-cold tumors, resistant to immune-checkpoint therapy and endogenous CXCL9/10 induction.
J Thorac Oncol
December 2024
Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA; Department of Medicine, University of California San Diego, La Jolla, CA 92037, USA; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Introduction: Copy-number (CN) loss of chromosome 9p, or parts thereof, impair immune response and confer ICT resistance by direct elimination of immune-regulatory genes on this arm, notably IFNγ genes at 9p24.1, and type-I interferon (IFN-I) genes at 9p21.3.
View Article and Find Full Text PDFTrace element zinc metabolism and its relation to tumors.
Front Endocrinol (Lausanne)
December 2024
Department of Urology, Kunming Children's Hospital, Kunming, Yunnan, China.
Zinc is an essential trace element in the human body, playing a crucial role in cellular metabolism.Dysregulation of zinc homeostasis can lead to abnormal cellular metabolism, contributing to diseases and closely related to tumor development. Adequate zinc intake can maintain zinc homeostasis in the body and support normal cellular metabolism.
View Article and Find Full Text PDFTumor cells induce neural DKK1 expression to promote MDSC infiltration and subsequent T cell suppression.
Cell Signal
December 2024
Department of Maxillofacial and Otorhinolaryngology Oncology and Department of Head and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China; National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China; Tianjin Key Laboratory of Basic and Translational Medicine on Head & Neck Cancer, Tianjin, China; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China. Electronic address:
Nerves are often overlooked as key components of the tumor microenvironment. However, the molecular mechanisms underlying the reciprocal interactions between tumors and nerves remain largely unknown. In this study, we analyzed data from The Cancer Genome Atlas (TCGA) and identified a significant association between DKK1 expression and poor prognosis, as well as a correlation between DKK1 expression and myeloid-derived suppressor cell (MDSC) infiltration in head and neck squamous cell carcinoma (HNSCC) and pancreatic ductal adenocarcinoma (PDAC), two cancer types characterized by pronounced tumor-nerve interactions.
View Article and Find Full Text PDFNSC-3852 synergistically enhances the cytotoxicity of olaparib in oral squamous cell carcinoma.
Biochem Biophys Res Commun
December 2024
Department of Pharmacology, Faculty of Dentistry, Osaka Dental University, 8-1 Kuzuhahanazono-cho, Hirakata, Osaka 573-1121, Japan. Electronic address:
The PARP inhibitor olaparib is an anti-cancer agent based on synthetic lethality that targets poly (ADP-ribose) polymerases. It is used as a therapeutic agent for breast, ovarian, pancreatic, and prostate cancers carrying BRCA1/2 mutations that cause deficiency in homologous recombination. In recent years, acquired resistance to PARP inhibitors has become a clinical problem in PARP inhibitor-treated patients.
View Article and Find Full Text PDFPPDPF Promotes Esophageal Squamous Cell Carcinoma Progression by Blocking PCCA Binding to PCCB and Inhibiting Methionine Catabolism.
Cancer Lett
December 2024
Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China. Electronic address:
While metabolic reprogramming and remodeling of tumor microenvironment play important roles in the development of esophageal squamous cell carcinoma (ESCC), the mechanisms remain unclear. In this study, we found that pancreatic progenitor cell differentiation and proliferation factor (PPDPF) is upregulated in ESCC and its expression level is associated with lymph node metastasis. PPDPF was found to promote tumorigenesis, lymph node metastasis and distal metastasis of ESCC cells.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!